Urokinase-Type Plasminogen Activator Downregulates Paraoxonase 1 Expression in Hepatocytes by Stimulating Peroxisome Proliferator–Activated Receptor-&ggr; Nuclear Export

@article{Khateeb2012UrokinaseTypePA,
  title={Urokinase-Type Plasminogen Activator Downregulates Paraoxonase 1 Expression in Hepatocytes by Stimulating Peroxisome Proliferator–Activated Receptor-&ggr; Nuclear Export},
  author={Jasmin Khateeb and Y. Kiyan and M. Aviram and S. Tkachuk and I. Dumler and B. Fuhrman},
  journal={Arteriosclerosis, Thrombosis, and Vascular Biology},
  year={2012},
  volume={32},
  pages={449–458}
}
  • Jasmin Khateeb, Y. Kiyan, +3 authors B. Fuhrman
  • Published 2012
  • Medicine, Biology
  • Arteriosclerosis, Thrombosis, and Vascular Biology
  • Objective—The atherosclerotic lesion is characterized by lipid peroxide accumulation. Paraoxonase 1 (PON1) reduces atherosclerotic lesion oxidative stress, whereas urokinase-type plasminogen activator (uPA) increases oxidative stress in atherosclerotic lesions and contributes to the progression and complications of atherosclerosis. We hypothesized that uPA may promote oxidative stress in the arterial wall via modulation of PON1 activity. Because the liver is the main site for PON1 production… CONTINUE READING
    Transcriptional regulation of human Paraoxonase 1 by nuclear receptors.
    13
    Beta-sitosterol upregulated paraoxonase-1 via peroxisome proliferator-activated receptor-γ in irradiated rats.
    7
    Regulation of Hepatic Paraoxonase-1 Expression
    30
    Skp2 Regulates Subcellular Localization of PPARγ by MEK Signaling Pathways in Human Breast Cancer
    7

    References

    Publications referenced by this paper.
    SHOWING 1-10 OF 47 REFERENCES